-
June 1, 2023 The Largest Phase 3 Trial on Psilocybin for Depression Has Kicked OffThe largest Phase 3 clinical trial investigating the efficacy and tolerability of psilocybin for treatment-resistant...
-
May 4, 2023 First Patient Dosed in Beckley Psytech’s Phase IIa Study of BPL-003 for Treatment Resistant DepressionBeckley Psytech’s Phase IIa study will explore the safety, efficacy and pharmacokinetics of a single dose of...
-
May 1, 2023 Shrooms vs. LSD: Differences, Similarities & Research ProgressA direct comparison between the subjective effects, onset time, mystical experience and research of shrooms...
